Category1 Registration Type Fee
Club Member CSCC Members $150.00 plus applicable taxes
  Non-Members $175.00 plus applicable taxes
Single Roundtable CSCC Members $25.00 plus applicable taxes
  Non-Members $30.00 plus applicable taxes

All CSCC Education Roundtables will be held on Thursdays and will be one (1) hour in length.
Eastern Pacific Mountain Central Atlantic Newfoundland
ON, QC BC AB, SK* MB, ON (West) NB, NS, PE, Lab NL
11:30-12:30 08:30-09:30 09:30-10:30 10:30-11:30 12:30-13:30 13:30-14:30
14:00-15:00 11:00-12:00 12:00-13:00 13:00-1400 15:00-16:00 16:00-17:00
* SK - During daylight savings time; otherwise one hour later

Register HERE Today!

1Save today! Club members are entitled to join any or all of the Roundtables. Register once only once automatically receive an invitation for each Roundtable and access to the slides and recordings of past roundtables for the current year.

  • Registration is by pre-payment only using the online registration form.
  • Each registration is restricted to one (1) phone line; you may have as many participants using that line as you wish.
  • Participants will be sent a 1-800 phone number for the audio and an internet url to view the slides.


2019-2020 SCHEDULE


  Date Time (Eastern) Presenter(s) Topic
 1 September 26, 2019  11:30-12:30  Ihssan Bouhtiauy, Daniel Gauthier, David Richardson Quality improvements from Canadian laboratories
 2 October 10, 2019  14:00-15:00  Daniel Beriault, Bradley Langford Use of procalcitonin to reduce antibiotic duration in ICU sepsis patients
 3 October 24, 2019  11:30-12:30  Vilte Barakauskas, Ashley Newbigging 2019 Best CSCC poster awards
 4 November 7, 2019  11:30-12:30  Brock O'Neil, Zahraa Mohammed-Ali Screening for prostate cancer - how can we maximize any benefits while minimizing the risks?
Analytical aspects of PSA testing
 5 November 21, 2019  14:00-15:00  Nicole White Al-Habeeb Biotin interferences
 6 December 5, 2019  11:30-12:30  tba  
 7 January 9, 2020  11:30-12:30     
 8 January 23, 2020  11:30-12:30     
 9 February 6 , 2020  14:00-15:00     
 10 February 20. 2020 11:30-12:30   
 11 March 5, 2020 11:30-12:30     
 12 March 19, 2020 14:00-15:00     
 13 April 2, 2020  11:30-12:30     
 14 April 16, 2020  14:00-15:00     
 15 April 30, 2020 11:30-12:30     
 16 May 14, 2020  11:30-12:30     
 17 May 28, 2020  14:00-15:00     


#1 September 26, 2019 Quality Improvements from Canadian Laboratories
  Ihssan Bouhtiauy, Head, Department of Biochemistry, Vitalite Health Network 
  Since the last decade, there is a drive to manage laboratory test utilization. At our facility, we started laboratory test optimization in 1995 with the implementation of a decisional algorithm for TSH that allowed for reflex FT4. Since then, we implemented several different decisional algorithms (e.g. cardiac markers, coeliac, serum protein electrophoresis, testosterone, ANA/ENA; ANCA/anti-GBM). We also changed the list of tests included in many profiles (e.g. cardiac panel and lipid profiles). We discontinued obsolete tests (e.g. CK-MB, myoglobin, TT4, TT3, amylase) and significantly reduced the requests for other tests (e.g. vitamin D, folate, AST, measured LDL). Different approaches were used to implement these changes and an audit was done to evaluate if the target was achieved; if not, further adjustments were made. The results and financial benefit were very significant. The request for serum folate was reduced by 75% and 90% in two separate regional hospitals, respectively. AST was reduced by more than 85%.
At Vitalité Health Network, we have one university hospital, 3 regional hospitals and 6 community hospitals. We realized that the implementation of these changes is not “copy & paste”. In some cases, the approach to the implementation was different from one hospital to another and required good communication and collaboration with clinician colleagues. 
  At the end of this session, participants will be able to:
1)  understand different approaches used for the management of laboratory utilization
2)  be familiar with the positive impact of the management of laboratory utilization
3)  realize the importance of communication
  David Richardson, Infectious Diseases Consultant and Medical Microbiologist, William Osler Health System
  Clinical evaluation of the patient is key to best care and the optimal use of laboratory tests.  The majority of urine samples sent to the lab for culture are either negative or clinically unimportant.  At Osler, over 5,000 urine cultures were performed monthly with a positivity rate of only 16%.  Ideally, clinicians would not send a urine sample for culture when the patient is asymptomatic for a urinary tract infection.  We questioned whether clinically non-significant urines could be screened out to avoid setting them up for unnecessary culture.  Our study exhibited an accurate prediction for excluding non-significant urines in hospitalized patients with a rapid turaround time.  While markedly decreasing the number of urines being set up for culture there were no identified negative impacts to patient care.  Aside from the realized cost savings related to fewer urine cultures there may be downstream savings related to imporved antimicrobial usage and even decreased length of stay (LOS).
   At the end of this session, participants will be able to:
1)  appreciate the clinical impact of unnecessary urine cultures to patients, physicians and the healthcare system
2)  understand how urine flow cytometry technology can be used to select out clinically non-significant urines to avoid unnecessary culture
3)  appreicate that this quality initiative, which involved a forcing function, safely led to a significant reduction in unnecessary urine cultures and spent resources while improving patient care.
  Daniel Gauthier, Head of Regional Biochemistry Service, CISSS Montérégie-Centre 
  Regional and provincial laboratory reorganizations and restructurations are currently occuring across Canada in order to optimize the efficiency of laboratory services.  In this presentation, we will review the challenges associated with such changes from a clinico-administrative point of view that were experienced in Montérégie, Quebec.  We will also describe the mechanisms and solutions that were developed in order to overcome those challenges and move forward in an efficient manner. 
  At the end of this session, participants will be able to:
1)   anticipate and identify challenges associated with large-scale laboratory reorganisation from a clinico-administrative point of view
2)  develop locally adapted solutions and structures in which a large team of biochemists will be able to cooperate and contriubte efficiently to the unified laboratory, while respecting the expertise and interests of everyone.